tiprankstipranks
Advertisement
Advertisement
The Week That Was, The Week Ahead: Macro and Markets, May 10
PremiumMarket NewsThe Week That Was, The Week Ahead: Macro and Markets, May 10
1M ago
ResMed Earnings Call Highlights Margin Strength, Growth
Premium
Company Announcements
ResMed Earnings Call Highlights Margin Strength, Growth
2M ago
ResMed price target lowered to $225 from $254 at Baird
Premium
The Fly
ResMed price target lowered to $225 from $254 at Baird
2M ago
ResMed Delivers Strong Q3 Results and Margin Expansion
PremiumCompany AnnouncementsResMed Delivers Strong Q3 Results and Margin Expansion
2M ago
ResMed Announces CFO Transition and Confirms Growth Strategy
Premium
Company Announcements
ResMed Announces CFO Transition and Confirms Growth Strategy
2M ago
ResMed reports Q3 EPS $2.86, consensus $2.72
Premium
The Fly
ResMed reports Q3 EPS $2.86, consensus $2.72
2M ago
ResMed: Buy Rating on Depressed Valuation as Market Overprices Philips and GLP‑1 Risks
PremiumRatingsResMed: Buy Rating on Depressed Valuation as Market Overprices Philips and GLP‑1 Risks
2M ago
ResMed initiated with an Overweight at JPMorgan
Premium
The Fly
ResMed initiated with an Overweight at JPMorgan
2M ago
ResMed price target lowered to $255 from $300 at Evercore ISI
Premium
The Fly
ResMed price target lowered to $255 from $300 at Evercore ISI
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100